CDK1/4/6 inhibitor (Shanghai Haihe Pharmaceutial)

N/A

Report date: 2025/03/18 18:11:52
NME

Base Information

Drug NameCDK1/4/6 inhibitor (Shanghai Haihe Pharmaceutial)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 1 inhibitorsCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 6 inhibitors
TargetsCyclin-dependent kinase 1Cyclin-dependent kinase 6Cyclin-dependent kinase 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShangHai HaiHe Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShangHai HaiHe Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A